Ivabradine eligibility — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Optimise standard heart failure and rate-control therapy rather than ivabradine
Ivabradine reduces heart rate by acting on the sinus node and is not effective for rate control in atrial fibrillation. It has specific criteria in heart failure, including sinus rhythm and appropriate heart-rate threshold. Atrial fibrillation requires separate rate or rhythm management and stroke prevention assessment. Verapamil is also problematic in many patients with reduced ejection fraction.
Reference: BNF; NICE CKS